| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 55.6% | 20/36 |
| Female | 44.4% | 16/36 |
| Indifferent | 0% | 0/36 |
| Unknown | 0% | 0/36 |
| General | ||
| Birth Length | 0% | 0/36 |
| 11.1% | 4/36 | |
| 2.8% | 1/36 | |
| 5.6% | 2/36 | |
| 16.7% | 6/36 | |
| 8.3% | 3/36 | |
| 86.1% | 31/36 | |
| 83.3% | 30/36 | |
| 55.6% | 20/36 | |
| 85% | 17/20 | |
| Neurology | ||
| 58.3% | 21/36 | |
| 77.8% | 28/36 | |
| 19.4% | 7/36 | |
| Facial abnormalities | ||
| 25% | 9/36 | |
| 72.2% | 26/36 | |
| 44.4% | 16/36 | |
| 69.4% | 25/36 | |
| Visual and hearing impairments | ||
| 13.9% | 5/36 | |
| 41.7% | 15/36 | |
| Heart | ||
| 16.7% | 6/36 | |
| Pulmonary | ||
| 33.3% | 1/3 | |
| Gastrointestinal | ||
| 16.7% | 6/36 | |
| Urogenital | ||
| 16.7% | 6/36 | |
| Skeleton | ||
| 66.7% | 24/36 | |
| Skin / Hair / Nails | ||
| 33.3% | 12/36 | |
| Endocrine / Immunological / Metabolic | ||
| 11.1% | 4/36 | |
| Metabolic | 0% | 0/36 |
| 5.6% | 2/36 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/36 |
| Inheritance | ||
| 77.8% | 28/36 | |
SRCAP